Details for 2018806547

Up to date per 01.04.2026

Actions

Title / Product Name

VERFAHREN ZUR VERWENDUNG VON LÖSLICHEM CD24 ZUR BEHANDLUNG VON IMMUNBEDINGTEN UNERWÜNSCHTEN EREIGNISSEN IN KREBSTHERAPIEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2018806547

EP Publication Number

3630158

E-Number

1503915

Language

PCT Number

US18033728

Publication Date

08.04.2020 A

13.07.2022 B1

Registration Date

13.07.2022

AT Publication Date

15.08.2022

Application Date

21.05.2018

Registration Number

Priorities

22.05.2017

201762509498 P

IPC

A61K 38/17 20060101AFI20201208BHEP

Maximum Duration of Protection

21.05.2038

Owner

Oncoimmune, Inc.9430 Key West Avenue Suite 113 Rockville, Maryland 20850US

Children's National Medical Center111 Michigan Avenue N.W. Washington, DC 20010US

Representative

No representatives present

Inventor

LIU, Yang502 E Street NE Washington District of Columbia 20002US

ZHENG, Pan502 E Street NE Washington District of Columbia 20002US

DEVENPORT, Martin614 Still Creek Lane Gaithersburg Maryland 20878US

LIU, Mingyue2301 Wheatley Drive Apt 203 Baltimore, Maryland 21207US